FDA Drug Application (202211) for OXYTROL FOR WOMEN by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number202211
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage3.9MG/24HR
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOXYTROL FOR WOMEN
Active IngredientOXYBUTYNIN

Active IngredientCount
List of drugs with Active Ingredient OXYBUTYNIN4


Back to FDA Applications sponsored by ALLERGAN SALES LLC